Mainz Biomed B.V. (MYNZ) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Mainz Biomed announced a 1-for-40 reverse stock split to maintain its Nasdaq listing, aiming to boost its stock price and attract investors. The reverse split, effective December 3, 2024, will adjust the trading price of its shares but leave shareholder ownership percentages unchanged. This move comes after failing to meet Nasdaq’s minimum bid price and stockholders’ equity requirements.
For further insights into MYNZ stock, check out TipRanks’ Stock Analysis page.
